Literature DB >> 32965368

Renal changes and acute kidney injury in covid-19: a systematic review.

Samuel Átila Rodrigues Nogueira1, Samuel Ciríaco Silva de Oliveira1, Ana Flávia Moreira de Carvalho1, Julia Moreira Cavalcante Neves1, Leila Silveira Vieira da Silva1, Geraldo Bezerra da Silva Junior2, Maria Elizabeth Pereira Nobre1.   

Abstract

OBJECTIVE: We aimed to present a review of renal changes in patients with COVID-19.
METHODS: We performed a systematic review of the literature to identify original articles regarding clinical, laboratory, and anatomopathological kidney changes in patients infected with SARS-CoV-2 published until May 7, 2020. The search was carried out across PubMed, Scopus, and Embase using the keywords "COVID-19", "coronavirus", "SARS-CoV-2", "kidney injury" and "kidney disease". Fifteen studies presented clinical and laboratory renal changes in patients with COVID-19, and three addressed anatomopathological changes. DISCUSSION: Acute kidney injury (AKI) was a relevant finding in patients with COVID-19. There were also significant changes in laboratory tests that indicated kidney injury, such as increased serum creatinine and blood urea nitrogen (BUN), proteinuria, and hematuria. The presence of laboratory abnormalities and AKI were significant in severely ill patients. There was a considerable prevalence of AKI among groups of patients who died of COVID-19. Histopathological analysis of the kidney tissue of patients infected with SARS-CoV-2 suggested that the virus may directly affect the kidneys.
CONCLUSION: Although COVID-19 affects mainly the lungs, it can also impact the kidneys. Increased serum creatinine and BUN, hematuria, proteinuria, and AKI were frequent findings in patients with severe COVID-19 and were related to an increased mortality rate. Further studies focusing on renal changes and their implications for the clinical condition of patients infected with the novel coronavirus are needed.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32965368     DOI: 10.1590/1806-9282.66.S2.112

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  8 in total

1.  Predictive Model of Severity in SARS CoV-2 Patients at Hospital Admission Using Blood-Related Parameters.

Authors:  Laura Criado Gómez; Santiago Villanueva Curto; Maria Belén Pérez Sebastian; Begoña Fernández Jiménez; Melisa Duque Duniol
Journal:  EJIFCC       Date:  2021-06-29

Review 2.  The Role of Biomarkers in Hospitalized COVID-19 Patients With Systemic Manifestations.

Authors:  Michael Schneider
Journal:  Biomark Insights       Date:  2022-06-26

3.  Preeclampsia among women with COVID-19 during pregnancy and its impact on maternal and perinatal outcomes: Results from a national multicenter study on COVID in Brazil, the REBRACO initiative.

Authors:  José P Guida; Jose G Cecatti; Renato T Souza; Rodolfo C Pacagnella; Carolina C Ribeiro-do-Valle; Adriana G Luz; Giuliane J Lajos; Fernanda G Surita; Guilherme M Nobrega; Thayna B Griggio; Charles M Charles; Maria J Miele; Silvana B Ferreira; Ricardo P Tedesco; Karayna G Fernandes; Sérgio H A Martins-Costa; José G L Ramos; Frederico J A Peret; Francisco E Feitosa; Evelyn Traina; Edson V Cunha-Filho; Janete Vettorazzi; Samira M Haddad; Carla B Andreucci; Mário D Correa-Junior; Jussara Mayrink; Marcos A B Dias; Leandro G Oliveira; Elias F Melo-Junior; Marília G Q da Luz; Maria Laura Costa
Journal:  Pregnancy Hypertens       Date:  2022-05-10       Impact factor: 2.494

4.  Renal Manifestations and their Association with Mortality and Length of Stay in COVID-19 Patients at a Safety-net Hospital.

Authors:  Sandra Gomez-Paz; Eric Lam; Luis Gonzalez-Mosquera; Diana Cardenas-Maldonado; Joshua Fogel; Ellen Gabrielle Kagan; Sofia Rubinstein
Journal:  J Crit Care Med (Targu Mures)       Date:  2022-05-12

Review 5.  Potential of Omega 3 Supplementation for Coronavirus Disease 2019 (COVID-19): A Scoping Review.

Authors:  Nanda Nursyifa Fadiyah; Ginna Megawati; Dimas Erlangga Luftimas
Journal:  Int J Gen Med       Date:  2022-04-11

6.  Identification of High Death Risk Coronavirus Disease-19 Patients using Blood Tests.

Authors:  Elaheh Zadeh Hosseingholi; Saeede Maddahi; Sajjad Jabbari; Ghader Molavi
Journal:  Adv Biomed Res       Date:  2022-07-29

7.  Dexpanthenol attenuates inflammatory damage and apoptosis in kidney and liver tissues of septic mice.

Authors:  Xi Zhao; Siquan Zhang; Hongyi Shao
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

8.  Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores.

Authors:  Marcello Covino; Giuseppe De Matteis; Maria Livia Burzo; Andrea Russo; Evelina Forte; Annamaria Carnicelli; Andrea Piccioni; Benedetta Simeoni; Antonio Gasbarrini; Francesco Franceschi; Claudio Sandroni
Journal:  J Am Geriatr Soc       Date:  2020-11-30       Impact factor: 7.538

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.